Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03189230
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DRC | 9-AMINO-N-[2-(4-MORPHOLINYL)ETHYL]- 4-ACRIDINECARBOXAMIDE | A | 1KCI | 0.71 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.74 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 3DCJ | 0.82 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 1WSV | 0.82 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.7 | |
NHR | 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN- 6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}- PENTANEDIOIC ACID | A,B | 1C3E | 0.73 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.76 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFR | 0.71 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1DAJ | 0.71 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFQ | 0.71 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFP | 0.71 | |
R78 | 4-{[(7R)-8-cyclopentyl-7-ethyl- 5-methyl-6-oxo-5,6,7,8-tetrahydropteridin- 2-yl]amino}-3-methoxy-N-(1-methylpiperidin- 4-yl)benzamide | A | 2RKU | 0.71 | |
I19 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.72 | |
N4D | N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4- d]pyrimidin-4-yl)amino]benzamide | A | 3CG2 | 0.71 | |
20A | 1-ethyl-N-(phenylmethyl)-4-(tetrahydro- 2H-pyran-4-ylamino)-1H-pyrazolo[3,4- b]pyridine-5-carboxamide | A | 3D3P | 0.75 | |
356 | 8-[(3R)-3-Aminopiperidin-1-yl]- 7-but-2-yn-1-yl-3-methyl-1-[(4- methylquinazolin-2-yl)methyl]-3,7- dihydro-1H-purine-2,6-dione | A,B | 2RGU | 0.71 | |
L0C | 4-{[2-(4-{[(4-FLUOROPHENYL)CARBONYL]AMINO}- 1H-PYRAZOL-3-YL)-1H-BENZIMIDAZOL- 6-YL]METHYL}MORPHOLIN-4-IUM | A | 2W1C | 0.74 | |
L34 | 4-(7-AMINO-9-HYDROXY-1-OXO-3,3A,4,5- TETRAHYDRO-2,5,6,8,9B-PENTAAZA- CYCLOPENTA[A]NAPHTHALEN-2-YL)-PHENYLCARBONYL- GLUTAMIC ACID | A,B | 1DIB | 0.79 | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.81 | |
IBI | N-{trans-4-[4-(cyclopropylmethyl)piperazin- 1-yl]cyclohexyl}-4-{[(7R)-7-ethyl- 5-methyl-8-(1-methylethyl)-6-oxo- 5,6,7,8-tetrahydropteridin-2-yl]amino}- 3-methoxybenzamide | A | 3FC2 | 0.7 | |
L24 | [[[2-AMINO-5,6,7,8-TETRAHYDRO-4- HYDROXY-PYRIDO[2,3-D]PYRIMIDIN- 6-YL]-ETHYL]-PHENYL]-CARBONYL-GLUTAMIC ACID | A,B | 1DIA | 0.74 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.82 | |
GPB | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.73 | |
PB4 | N,N'-BIS(4-FLUORO-3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUD | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.78 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.78 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.76 | |
DHF | DIHYDROFOLIC ACID | A,B,C,D,E | 3DL5 | 0.7 | |
DHF | DIHYDROFOLIC ACID | A | 1LCB | 0.7 | |
DHF | DIHYDROFOLIC ACID | A,B,C,D | 1MXH | 0.7 | |
DHF | DIHYDROFOLIC ACID | A | 2RK1 | 0.7 | |
DHF | DIHYDROFOLIC ACID | A | 1RF7 | 0.7 | |
DHF | DIHYDROFOLIC ACID | A,B,C,D,E | 3DL6 | 0.7 | |
DHF | DIHYDROFOLIC ACID | A | 1TYS | 0.7 | |
PB3 | N,N'-BIS(3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUC | 0.73 | |
MS1 | A,B | 1OZ0 | 0.72 | ||
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.7 | |
CKR | 6-amino-2-[(2-morpholin-4-ylethyl)amino]- 3,7-dihydro-8H-imidazo[4,5-g]quinazolin- 8-one | A | 3C2N | 0.72 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.77 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.77 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.77 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.77 | |
FOL | FOLIC ACID | A | 4CD2 | 0.77 | |
FOL | FOLIC ACID | A | 1RX7 | 0.77 | |
FOL | FOLIC ACID | A | 1RX2 | 0.77 | |
FOL | FOLIC ACID | A | 1RX8 | 0.77 | |
FOL | FOLIC ACID | A | 1RA2 | 0.77 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.77 | |
FOL | FOLIC ACID | A | 7DFR | 0.77 | |
FOL | FOLIC ACID | A | 1VIF | 0.77 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.77 | |
FOL | FOLIC ACID | A | 1CD2 | 0.77 | |
FOL | FOLIC ACID | A | 2CD2 | 0.77 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.77 | |
FOL | FOLIC ACID | A | 1DRF | 0.77 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.77 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.77 | |
FOL | FOLIC ACID | A | 1RA8 | 0.77 | |
GK6 | N-{4'-[(cyclopropylmethyl)carbamoyl]- 6-methylbiphenyl-3-yl}-2-morpholin- 4-ylpyridine-4-carboxamide | A | 3D83 | 0.7 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.85 | |
P38 | 5-methyl-4-[(2-methyl-5-{[(2-morpholin- 4-ylpyridin-4-yl)carbonyl]amino}phenyl)amino]- N-(1-phenylethenyl)pyrrolo[2,1- f][1,2,4]triazine-6-carboxamide | A | 3BV2 | 0.71 | |
P40 | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.75 | |
L37 | A,B | 1DIG | 0.79 | ||
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.71 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.71 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.71 | |
FXG | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | A | 3DAJ | 0.73 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.86 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.86 | |
MTX | METHOTREXATE | A | 1U70 | 0.86 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.86 | |
MTX | METHOTREXATE | A | 2QK8 | 0.86 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.86 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.86 | |
MTX | METHOTREXATE | A | 3DAU | 0.86 | |
MTX | METHOTREXATE | A | 1U72 | 0.86 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.86 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.86 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.86 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.86 | |
MTX | METHOTREXATE | A | 1RX3 | 0.86 | |
MTX | METHOTREXATE | A | 3DFR | 0.86 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.86 | |
MTX | METHOTREXATE | A | 3DAT | 0.86 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.86 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.86 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.86 | |
MTX | METHOTREXATE | A | 3EIG | 0.86 | |
MTX | METHOTREXATE | A | 3CD2 | 0.86 | |
MTX | METHOTREXATE | A | 1AO8 | 0.86 | |
MTX | METHOTREXATE | A | 1DF7 | 0.86 | |
MTX | METHOTREXATE | A | 1DLS | 0.86 | |
MTX | METHOTREXATE | A | 1RG7 | 0.86 | |
MTX | METHOTREXATE | A | 1RH3 | 0.86 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.86 | |
MTX | METHOTREXATE | A | 1RA3 | 0.86 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.86 | |
MTX | METHOTREXATE | A | 1DRE | 0.86 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.86 | |
MTX | METHOTREXATE | A | 3CL9 | 0.86 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.86 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.86 | |
3BI | (2S)-2-{[(R)-[(3R)-3-carboxy-3- {[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}propyl](hydroxy)phosphoryl]methyl}pentanedioic acid | A | 3BI1 | 0.82 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.74 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.74 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.74 |